Clinical Trial Update: Alirocumab in Patients on a Stable Dialysis Regimen [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating alirocumab in patients on stable dialysis regimens to assess lipid-lowering efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Disease
• Hemodialysis
• Hypercholesterolemia
• Peritoneal Dialysis

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Baylor Research Institute | Conditions: Hemodialysis, Peritoneal Dialysis | Phase 3 | Status: UNKNOWN